🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06725199
Enrolling by invitation Observational

Metabolomic Profiling Based on Nuclear Magnetic Resonance in Fibromyalgia Patients

NCT06725199 · tracked via the Priya Life Science Turkey tracker
Sponsor
hatice kübra aşık
Phase
Observational
Started
2024-09-01
Last updated
2024-12-10

Condition(s) studied

Patients with Clinical Complaints of Fibromyalgia Among the Patients Applying to the Outpatient ClinicFibromyalgia Syndrome

Study summary

Evaluation of sera of fibromyalgia patients in terms of energy metabolism function and possible alterations in metabolism predisposing to various degenerative/proliferative diseases.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: patients aged 18-65 years Patients with clinical complaints of fibromyalgia Exclusion Criteria: Viral or bacterial infections, Diabetes mellitus, Hypertension, Chronic renal failure, Hypo-hyperthyroidism) Patients taking antidepressants or medication, Smokers and alcohol users, Patients with rheumatic arthritis and systemic lupus erythematosus were excluded. \-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Beykent Istanbul Istanbul

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06725199 on ClinicalTrials.gov ↗ ← All trials in Turkey